Skip to Main Content

Paper Details

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Cancer Cell
41
2022
Author NameAffiliation
Jianjun ZhangThe University of Texas M.D. Anderson Cancer Center
Charles LuThe University of Texas M.D. Anderson Cancer Center
Mark J RoutbortThe University of Texas M.D. Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2